GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » Price-to-Free-Cash-Flow

TSH Biopharm (ROCO:8432) Price-to-Free-Cash-Flow : 28.14 (As of Jun. 13, 2024)


View and export this data going back to 2012. Start your Free Trial

What is TSH Biopharm Price-to-Free-Cash-Flow?

As of today (2024-06-13), TSH Biopharm's share price is NT$64.00. TSH Biopharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$2.27. Hence, TSH Biopharm's Price-to-Free-Cash-Flow Ratio for today is 28.14.

The historical rank and industry rank for TSH Biopharm's Price-to-Free-Cash-Flow or its related term are showing as below:

ROCO:8432' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.94   Med: 40.52   Max: 351.43
Current: 28.15

During the past 13 years, TSH Biopharm's highest Price-to-Free-Cash-Flow Ratio was 351.43. The lowest was 11.94. And the median was 40.52.

ROCO:8432's Price-to-Free-Cash-Flow is ranked worse than
55.98% of 527 companies
in the Drug Manufacturers industry
Industry Median: 22.78 vs ROCO:8432: 28.15

TSH Biopharm's Free Cash Flow per Share for the three months ended in Mar. 2024 was NT$1.39. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was NT$2.27.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of TSH Biopharm was 377.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 45.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -17.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -14.40% per year.

During the past 13 years, TSH Biopharm's highest 3-Year average Free Cash Flow per Share Growth Rate was 45.40% per year. The lowest was -50.60% per year. And the median was -5.55% per year.


TSH Biopharm Price-to-Free-Cash-Flow Historical Data

The historical data trend for TSH Biopharm's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TSH Biopharm Price-to-Free-Cash-Flow Chart

TSH Biopharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.28 245.42 24.94 117.12 68.25

TSH Biopharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.79 122.68 - 68.25 25.29

Competitive Comparison of TSH Biopharm's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, TSH Biopharm's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TSH Biopharm's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TSH Biopharm's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TSH Biopharm's Price-to-Free-Cash-Flow falls into.



TSH Biopharm Price-to-Free-Cash-Flow Calculation

TSH Biopharm's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=64.00/2.274
=28.14

TSH Biopharm's Share Price of today is NT$64.00.
TSH Biopharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.27.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

TSH Biopharm  (ROCO:8432) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


TSH Biopharm Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of TSH Biopharm's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


TSH Biopharm (ROCO:8432) Business Description

Traded in Other Exchanges
N/A
Address
No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115
TSH Biopharm Corp Ltd is engaged in the sale of a variety of pharmaceuticals, chemical drugs and biotechnology services. The Company's revenue is earned domestically.

TSH Biopharm (ROCO:8432) Headlines

No Headlines